{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:33:52Z","timestamp":1788345232080,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["MINECO- PCIN-2017-129\/ AEI"],"award-info":[{"award-number":["MINECO- PCIN-2017-129\/ AEI"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["A20\/00028"],"award-info":[{"award-number":["A20\/00028"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["GA N 723770"],"award-info":[{"award-number":["GA N 723770"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-86634-R"],"award-info":[{"award-number":["SAF2017-86634-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431C 2017\/09"],"award-info":[{"award-number":["ED431C 2017\/09"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481A-2018\/047"],"award-info":[{"award-number":["ED481A-2018\/047"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["ED481A-2018\/047"],"award-info":[{"award-number":["ED481A-2018\/047"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-126130OB-I00"],"award-info":[{"award-number":["PID2021-126130OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s13346-023-01441-5","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T07:22:16Z","timestamp":1696836136000},"page":"918-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Controlling the protein corona of polymeric nanocapsules: effect of polymer shell on protein adsorption"],"prefix":"10.1007","volume":"14","author":[{"given":"Germ\u00e1n","family":"Berrecoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Bel\u00e9n","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Arriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Abrescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-5010","authenticated-orcid":false,"given":"Jos\u00e9","family":"Crecente-Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,8]]},"reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.biotechadv.2017.08.003","volume":"35","author":"P Jain","year":"2017","unstructured":"Jain P, Pawar RS, Pandey RS, Madan J, Pawar S, Lakshmi PK, et al. In-vitro in-vivo correlation (IVIVC) in nanomedicine: is protein corona the missing link? Biotechnol Adv. 2017;35:889\u2013904.","journal-title":"Biotechnol Adv"},{"key":"1441_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s13346-020-00745-0","volume":"10","author":"G Berrecoso","year":"2020","unstructured":"Berrecoso G, Crecente-Campo J, Alonso MJ. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers. Drug Deliv Transl Res. 2020;10:730\u201350.","journal-title":"Drug Deliv Transl Res"},{"key":"1441_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.567365","volume":"11","author":"E Papini","year":"2020","unstructured":"Papini E, Tavano R, Mancin F. Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines. Front Immunol. 2020;11:1\u201319.","journal-title":"Front Immunol"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","volume":"18","author":"R Gref","year":"2000","unstructured":"Gref R, L\u00fcck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. \u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B: Biointerfaces. 2000;18:301\u201313.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1021\/nl302638g","volume":"12","author":"JL Perry","year":"2012","unstructured":"Perry JL, Reuter KG, Kai MP, Herlihy KP, Jones SW, Luft JC, et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 2012;12:5304\u201310.","journal-title":"Nano Lett"},{"key":"1441_CR6","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s11095-014-1355-x","volume":"31","author":"N Samadi","year":"2014","unstructured":"Samadi N, van Steenbergen MJ, van den Dikkenberg JB, Vermonden T, van Nostrum CF, Amidi M, et al. Nanoparticles based on a hydrophilic polyester with a sheddable PEG coating for protein delivery. Pharm Res. 2014;31:2593\u2013604.","journal-title":"Pharm Res"},{"key":"1441_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25:1467\u201375.","journal-title":"Mol Ther"},{"key":"1441_CR8","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","volume":"31","author":"V Francia","year":"2020","unstructured":"Francia V, Schiffelers RM, Cullis PR, Witzigmann D. The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug Chem. 2020;31:2046\u201359.","journal-title":"Bioconjug Chem"},{"key":"1441_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","volume":"25","author":"B Romberg","year":"2008","unstructured":"Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res. 2008;25:55\u201371.","journal-title":"Pharm Res"},{"key":"1441_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","volume":"145","author":"SD Li","year":"2010","unstructured":"Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release. 2010;145:178\u201381.","journal-title":"J Control Release"},{"key":"1441_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci. 2021;118: e2109256118.","journal-title":"Proc Natl Acad Sci"},{"key":"1441_CR12","doi-asserted-by":"crossref","unstructured":"Dawson KA, Yan Y. Current understanding of biological identity at the nanoscale and future prospects. Nat Nanotechnol. Springer US; 2021;16:229\u201342.","DOI":"10.1038\/s41565-021-00860-0"},{"key":"1441_CR13","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1073\/pnas.0608582104","volume":"104","author":"T Cedervall","year":"2007","unstructured":"Cedervall T, Lynch I, Lindman S, Bergg\u00e5rd T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci. 2007;104:2050\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1441_CR14","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1158\/1078-0432.CCR-18-2381","volume":"25","author":"\u00c1 Molina-Crespo","year":"2019","unstructured":"Molina-Crespo \u00c1, Cadete A, Sarrio D, G\u00e1mez-Chiachio M, Martinez L, Chao K, et al. Intracellular delivery of an antibody targeting gasdermin-B reduces HER2 breast cancer aggressiveness. Clin Cancer Res. 2019;25:4846\u201358.","journal-title":"Clin Cancer Res"},{"key":"1441_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpharm.2016.05.034","volume":"509","author":"R Abellan-Pose","year":"2016","unstructured":"Abellan-Pose R, Teijeiro-Vali\u00f1o C, Santander-Ortega MJ, Borrajo E, Vidal A, Garcia-Fuentes M, et al. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: effect of the particle size. Int J Pharm. 2016;509:107\u201317.","journal-title":"Int J Pharm"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2018.12.041","volume":"295","author":"AM Ledo","year":"2019","unstructured":"Ledo AM, Sasso MS, Bronte V, Marigo I, Boyd BJ, Garcia-Fuentes M, et al. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells. J Control Release. 2019;295:60\u201373.","journal-title":"J Control Release"},{"key":"1441_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2013.03.037","volume":"169","author":"T Gonzalo","year":"2013","unstructured":"Gonzalo T, Lollo G, Garcia-Fuentes M, Torres D, Correa J, Riguera R, et al. A new potential nano-oncological therapy based on polyamino acid nanocapsules. J Control Release. 2013;169:10\u20136.","journal-title":"J Control Release"},{"key":"1441_CR18","doi-asserted-by":"crossref","unstructured":"Crecente-Campo J, Lorenzo-Abalde S, Mora A, Marzoa J, Csaba N, Blanco J, et al. Bilayer polymeric nanocapsules: a formulation approach for a thermostable and adjuvanted E. coli antigen vaccine. J Control Release. 2018;286:20\u201332.","DOI":"10.1016\/j.jconrel.2018.07.018"},{"key":"1441_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ejpb.2019.07.016","volume":"142","author":"S Reimondez-Troiti\u00f1o","year":"2019","unstructured":"Reimondez-Troiti\u00f1o S, Gonz\u00e1lez-Aramundiz JV, Ruiz-Ba\u00f1obre J, L\u00f3pez-L\u00f3pez R, Alonso MJ, Csaba N, et al. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells. Eur J Pharm Biopharm. 2019;142:449\u201359.","journal-title":"Eur J Pharm Biopharm"},{"key":"1441_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejpb.2014.02.004","volume":"87","author":"G Lollo","year":"2014","unstructured":"Lollo G, Rivera-Rodriguez GR, Bejaud J, Montier T, Passirani C, Benoit JP, et al. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel. Eur J Pharm Biopharm. 2014;87:47\u201354.","journal-title":"Eur J Pharm Biopharm"},{"key":"1441_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/btm2.10118","volume":"4","author":"J Crecente-Campo","year":"2019","unstructured":"Crecente-Campo J, Alonso MJ. Engineering, on-demand manufacturing, and scaling-up of polymeric nanocapsules. Bioeng Transl Med. 2019;4:38\u201350.","journal-title":"Bioeng Transl Med"},{"key":"1441_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jconrel.2018.12.002","volume":"294","author":"C Teijeiro-Vali\u00f1o","year":"2019","unstructured":"Teijeiro-Vali\u00f1o C, Novoa-Carballal R, Borrajo E, Vidal A, Alonso-Nocelo M, de la Fuente FM, et al. A multifunctional drug nanocarrier for efficient anticancer therapy. J Control Release. 2019;294:154\u201364.","journal-title":"J Control Release"},{"key":"1441_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2016.11.012","volume":"245","author":"JV Gonz\u00e1lez-Aramundiz","year":"2017","unstructured":"Gonz\u00e1lez-Aramundiz JV, Presas E, Dalmau-Mena I, Mart\u00ednez-Pulgar\u00edn S, Alonso C, Escribano JM, et al. Rational design of protamine nanocapsules as antigen delivery carriers. J Control Release. 2017;245:62\u20139.","journal-title":"J Control Release"},{"key":"1441_CR24","doi-asserted-by":"crossref","unstructured":"Robla S, Prasanna M, Varela-Calvi\u00f1o R, Grandjean C, Csaba N. A chitosan-based nanosystem as pneumococcal vaccine delivery platform. Drug Deliv Transl Res. Springer US; 2021;11:581\u201397.","DOI":"10.1007\/s13346-021-00928-3"},{"key":"1441_CR25","doi-asserted-by":"crossref","unstructured":"Borrajo E, Abellan-Pose R, Soto A, Garcia-Fuentes M, Csaba N, Alonso MJMJMJ, et al. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer. J Control Release. Elsevier B.V.; 2016;238:263\u201371.","DOI":"10.1016\/j.jconrel.2016.07.048"},{"key":"1441_CR26","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Mari\u00f1o I, Anfray C, Crecente-Campo J, Maeda A, Ummarino A, Teijeiro-Vali\u00f1o C, et al. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages. Drug Deliv Transl Res. Springer US; 2022;Online ahead of print.","DOI":"10.21203\/rs.3.rs-1918243\/v1"},{"key":"1441_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijpharm.2015.02.028","volume":"483","author":"G Lollo","year":"2015","unstructured":"Lollo G, Hervella P, Calvo P, Avil\u00e9s P, Guillen MJ, Garcia-Fuentes M, et al. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative. Int J Pharm. 2015;483:212\u20139.","journal-title":"Int J Pharm"},{"key":"1441_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/1061186X.2018.1561886","volume":"27","author":"AS Cordeiro","year":"2019","unstructured":"Cordeiro AS, Crecente-Campo J, Bouzo BL, Gonz\u00e1lez SF, de la Fuente M, Alonso MJ. Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system. J Drug Target. 2019;27:646\u201358.","journal-title":"J Drug Target"},{"key":"1441_CR29","doi-asserted-by":"crossref","unstructured":"Dur\u00e1n-Lobato M, L\u00f3pez-Est\u00e9vez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, et al. Nanotechnologies for the delivery of biologicals: historical perspective and current landscape. Adv Drug Deliv Rev. 2021;176.","DOI":"10.1016\/j.addr.2021.113899"},{"key":"1441_CR30","doi-asserted-by":"crossref","unstructured":"Chetwynd AJ, Wheeler KE, Lynch I. Best practice in reporting corona studies: Minimum Information about Nanomaterial Biocorona Experiments (MINBE). Nano Today. Elsevier Ltd; 2019;28:100758.","DOI":"10.1016\/j.nantod.2019.06.004"},{"key":"1441_CR31","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1038\/s41598-019-47995-8","volume":"9","author":"A Cadete","year":"2019","unstructured":"Cadete A, Olivera A, Besev M, Dhal PK, Gon\u00e7alves L, Almeida AJ, et al. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs. Sci Rep. 2019;9:11565.","journal-title":"Sci Rep"},{"key":"1441_CR32","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s13346-022-01150-5","volume":"12","author":"G Berrecoso","year":"2022","unstructured":"Berrecoso G, Crecente-Campo J, Alonso MJ. Quantification of the actual composition of polymeric nanocapsules: a quality control analysis. Drug Deliv Transl Res. 2022;12:2865\u201374.","journal-title":"Drug Deliv Transl Res"},{"key":"1441_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s13346-019-00678-3","volume":"10","author":"E Samaridou","year":"2020","unstructured":"Samaridou E, Kalamidas N, Santalices I, Crecente-Campo J, Alonso MJ. Tuning the PEG surface density of the PEG-PGA enveloped octaarginine-peptide nanocomplexes. Drug Deliv Transl Res. 2020;10:241\u201358.","journal-title":"Drug Deliv Transl Res"},{"key":"1441_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actbio.2015.03.001","volume":"19","author":"KL Lee","year":"2015","unstructured":"Lee KL, Shukla S, Wu M, Ayat NR, El Sanadi CE, Wen AM, et al. Stealth filaments: polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X. Acta Biomater. 2015;19:166\u201379.","journal-title":"Acta Biomater"},{"key":"1441_CR35","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1002\/anie.202004611","volume":"59","author":"JB Simonsen","year":"2020","unstructured":"Simonsen JB, M\u00fcnter R. Pay attention to biological nanoparticles when studying the protein corona on nanomedicines. Angew Chemie - Int Ed. 2020;59:12584\u20138.","journal-title":"Angew Chemie - Int Ed"},{"key":"1441_CR36","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1441_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2016.10.002","volume":"243","author":"LN Thwala","year":"2016","unstructured":"Thwala LN, Beloqui A, Csaba NS, Gonz\u00e1lez-Touceda D, Tovar S, Dieguez C, et al. The interaction of protamine nanocapsules with the intestinal epithelium: a mechanistic approach. J Control Release. 2016;243:109\u201320.","journal-title":"J Control Release"},{"key":"1441_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2217\/nnm.14.39","volume":"9","author":"D Dell\u2019Orco","year":"2014","unstructured":"Dell\u2019Orco D, Lundqvist M, Linse S, Cedervall T. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems. Nanomedicine. 2014;9:851\u20138.","journal-title":"Nanomedicine"},{"key":"1441_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175871","volume":"12","author":"M Lundqvist","year":"2017","unstructured":"Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlb\u00e4ck B, Linse S, et al. The nanoparticle protein corona formed in human blood or human blood fractions. PLoS ONE. 2017;12: e0175871.","journal-title":"PLoS ONE"},{"key":"1441_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/acs.biomac.7b01472","volume":"19","author":"LK M\u00fcller","year":"2018","unstructured":"M\u00fcller LK, Simon J, Rosenauer C, Mail\u00e4nder V, Morsbach S, Landfester K. The transferability from animal models to humans: challenges regarding aggregation and protein corona formation of nanoparticles. Biomacromol. 2018;19:374\u201385.","journal-title":"Biomacromol"},{"key":"1441_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.actbio.2018.02.036","volume":"71","author":"J M\u00fcller","year":"2018","unstructured":"M\u00fcller J, Prozeller D, Ghazaryan A, Kokkinopoulou M, Mail\u00e4nder V, Morsbach S, et al. Beyond the protein corona \u2013 lipids matter for biological response of nanocarriers. Acta Biomater. 2018;71:420\u201331.","journal-title":"Acta Biomater"},{"key":"1441_CR42","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1021\/nn201950e","volume":"5","author":"S Tenzer","year":"2011","unstructured":"Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5:7155\u201367.","journal-title":"ACS Nano"},{"key":"1441_CR43","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1039\/C9NR09879H","volume":"12","author":"S Jiang","year":"2020","unstructured":"Jiang S, Prozeller D, Pereira J, Simon J, Han S, Wirsching S, et al. Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsules. Nanoscale. 2020;12:2626\u201337.","journal-title":"Nanoscale"},{"key":"1441_CR44","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/mabi.201000496","volume":"11","author":"N Bege","year":"2011","unstructured":"Bege N, Renette T, Jansch M, Reul R, Merkel O, Petersen H, et al. Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with \u201cstealth\u201d potential. Macromol Biosci. 2011;11:897\u2013904.","journal-title":"Macromol Biosci"},{"key":"1441_CR45","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1002\/anie.200700465","volume":"46","author":"T Cedervall","year":"2007","unstructured":"Cedervall T, Lynch I, Foy M, Bergg\u00e5rd T, Donnelly SC, Cagney G, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chemie - Int Ed. 2007;46:5754\u20136.","journal-title":"Angew Chemie - Int Ed"},{"key":"1441_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejpb.2005.02.006","volume":"60","author":"TM G\u00f6ppert","year":"2005","unstructured":"G\u00f6ppert TM, M\u00fcller RH. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm. 2005;60:361\u201372.","journal-title":"Eur J Pharm Biopharm"},{"key":"1441_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0378-5173(99)00432-9","volume":"196","author":"A Gessner","year":"2000","unstructured":"Gessner A, Waicz R, Lieske A, Paulke BR, M\u00e4der K, M\u00fcller RH. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm. 2000;196:245\u20139.","journal-title":"Int J Pharm"},{"key":"1441_CR48","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1038\/s41467-019-11642-7","volume":"10","author":"F Giulimondi","year":"2019","unstructured":"Giulimondi F, Digiacomo L, Pozzi D, Palchetti S, Vulpis E, Capriotti AL, et al. Interplay of protein corona and immune cells controls blood residency of liposomes. Nat Commun. 2019;10:3686.","journal-title":"Nat Commun"},{"key":"1441_CR49","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1039\/C7NR07450F","volume":"10","author":"G Caracciolo","year":"2018","unstructured":"Caracciolo G. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona. Nanoscale. 2018;10:4167\u201372.","journal-title":"Nanoscale"},{"key":"1441_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/pharmaceutics11010031","volume":"11","author":"S Palchetti","year":"2019","unstructured":"Palchetti S, Caputo D, Digiacomo L, Capriotti A, Coppola R, Pozzi D, et al. Protein corona fingerprints of liposomes: new opportunities for targeted drug delivery and early detection in pancreatic cancer. Pharmaceutics. 2019;11:31.","journal-title":"Pharmaceutics"},{"key":"1441_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.taap.2005.07.017","volume":"210","author":"P Pande","year":"2006","unstructured":"Pande P, Mosleh TA, Aust AE. Role of \u03b1v\u03b25 integrin receptor in endocytosis of crocidolite and its effect on intracellular glutathione levels in human lung epithelial (A549) cells. Toxicol Appl Pharmacol. 2006;210:70\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1441_CR52","first-page":"247","volume":"2013","author":"G Caracciolo","year":"2013","unstructured":"Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Cardarelli F, Salomone F, Exploiting the \u201cprotein corona effect\u201d for targeted drug and gene delivery. Nanotechnol, et al. Bio Sensors, Instruments, Medical, Environ. Energy. 2013;2013:247\u201350.","journal-title":"Energy"},{"key":"1441_CR53","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Jayaprakash KN, et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther. 2010;18:1357\u201364.","journal-title":"Mol Ther"},{"key":"1441_CR54","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","volume":"13","author":"JA Kulkarni","year":"2017","unstructured":"Kulkarni JA, Myhre JL, Chen S, Tam YYC, Danescu A, Richman JM, et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine Nanotechnology, Biol Med. 2017;13:1377\u201387.","journal-title":"Nanomedicine Nanotechnology, Biol Med"},{"key":"1441_CR55","doi-asserted-by":"publisher","first-page":"18806","DOI":"10.1039\/C9NR05788A","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen D, Parayath N, Ganesh S, Wang W, Amiji M. The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models. Nanoscale. 2019;11:18806\u201324.","journal-title":"Nanoscale"},{"key":"1441_CR56","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang R, El-Mayta R, Murdoch TJ, Warzecha CC, Billingsley MM, Shepherd SJ, et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater Sci. 2021;9:1449\u201363.","journal-title":"Biomater Sci"},{"key":"1441_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00600-w","volume":"8","author":"N Bertrand","year":"2017","unstructured":"Bertrand N, Grenier P, Mahmoudi M, Lima EM, Appel EA, Dormont F, et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat Commun. 2017;8:1\u20138.","journal-title":"Nat Commun"},{"key":"1441_CR58","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajps.2019.05.002","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Zhu J, Wang Y, Zhou M, Li D, Zheng S, et al. In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy. Asian J Pharm Sci. 2020;15:482\u201391.","journal-title":"Asian J Pharm Sci"},{"key":"1441_CR59","doi-asserted-by":"publisher","first-page":"36092","DOI":"10.1074\/jbc.M201943200","volume":"277","author":"S Bultel-Brienne","year":"2002","unstructured":"Bultel-Brienne S, Lestavel S, Pilon A, Laffont I, Tailleux A, Fruchart JC, et al. Lipid free apolipoprotein E binds to the class B type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J Biol Chem. 2002;277:36092\u20139.","journal-title":"J Biol Chem"},{"key":"1441_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-016-0099-y","volume":"11","author":"Y Fu","year":"2016","unstructured":"Fu Y, Zhao J, Atagi Y, Nielsen HM, Liu CC, Zheng H, et al. Apolipoprotein e lipoprotein particles inhibit amyloid-\u03b2 uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener. 2016;11:1\u201311.","journal-title":"Mol Neurodegener"},{"key":"1441_CR61","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.4049\/jimmunol.1203194","volume":"190","author":"C Neyen","year":"2013","unstructured":"Neyen C, Pl\u00fcddemann A, Mukhopadhyay S, Maniati E, Bossard M, Gordon S, et al. Macrophage scavenger receptor A promotes tumor progression in murine models of ovarian and pancreatic cancer. J Immunol. 2013;190:3798\u2013805.","journal-title":"J Immunol"},{"key":"1441_CR62","first-page":"1","volume":"3","author":"S Vasseur","year":"2016","unstructured":"Vasseur S, Guillaumond F. LDL receptor: an open route to feed pancreatic tumor cells. Mol Cell Oncol. 2016;3:1\u20133.","journal-title":"Mol Cell Oncol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T18:10:02Z","timestamp":1710439802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01441-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,8]]},"assertion":[{"value":"27 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The plasma samples were obtained from anonymous healthy blood donors at the Servizo de Vixilancia da Sa\u00fade of the Universidade de Santiago de Compostela, Spain, under Spanish and European law, and with the approval of the Santiago and Lugo research ethic committee (Reference 2019_466).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of any result regarding the interaction of plasmatic proteins with nanosystems.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}